-
Pierre Fabre Buys Igenica Immuno-oncology Assets
contractpharma
May 26, 2017
Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
-
LSNE, Selecta Biosciences Form Mfg. Pact
contractpharma
May 26, 2017
LSNE to provide drug substance manufacturing and fill/finish services
-
MilliporeSigma Develops New CRISPR Genome Editing Method
contractpharma
May 26, 2017
Aims to provide researchers with more experimental options and faster results
-
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
contractpharma
May 26, 2017
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Akebia Therapeutics Names CMO
contractpharma
May 26, 2017
Rita Jain, M.D. has been appointed senior vice president and chief medical officer, Akebia Therapeutics, Inc. Dr. Jain will be responsible for leading the clinical development of the company’s HIF pipeline...
-
Early MRI may lower costs for prostate cancer treatment
europeanpharmaceuticalreview
May 26, 2017
A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Cent
-
A strong EU IP framework guarantees future innovation for patients
europeanpharmaceuticalreview
May 26, 2017
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for
-
More needs to be done in cancer prevention and detection suggests report
europeanpharmaceuticalreview
May 26, 2017
While there have been improvements in some areas of cancer prevention and early detection, the use of potentially lifesaving measures is suboptimal and strongly influenced by individual behaviours
-
UK’s first cancer fighting proton beam therapy system arrives in Wales
europeanpharmaceuticalreview
May 26, 2017
The first high energy proton beam therapy system to be installed in the UK has arrived at The Rutherford Cancer Centre, South Wales.
-
Bonesupport enrols first patient in injectable bone graft substitute trial
europeanpharmaceuticalreview
May 26, 2017
Bonesupport, the Scandinavian medical technology company, has enrolled their first patient at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial.